Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotioc usage in Taiwan

Clinical Microbiology and Infection

Volumn 11, Issue 11, 2005, Pages 925-927

  Hsueh, P R ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antibiotic use; Erythromycin; Penicillin; Resistance; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; OXACILLIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; DRUG USE; HEALTH CARE POLICY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TAIWAN; TREATMENT INDICATION;

BACTERIA (MICROORGANISMS); PNEUMOCOCCUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 27544483791     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01245.x     Document Type: Article

References (8)

1. Hsueh PR. Taiwan struggles against antibiotic resistance. APUA Newslett 2004; 21: 5.
2. Hsueh PR, Luh KT. Antimicrobial resistance in Streptococcus pneumoniae, Taiwan. Emerg Infect Dis 2002; 8: 1487-1491.
3. Hsueh PR, Teng LJ, Wu TL et al. Telithromycin- and fluoroquinolone-resistant Streptococcus pneunioniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data. Antimicrob Agents Chemother 2003; 47: 2145-2151.
4. Hsueh PR, Liu YC, Shyr JM et al. Multicenter surveillance of antimicrobial resistance of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan during the 1998-1999 respiratory season. Antimicrob Agents Chemother 2000; 44: 1342-1345.
5. Ho M, Hsiung CA, Yu HT, Chi CL, Chang HJ. Changes before and after a policy to restrict antimicrobial usage in upper respiratory tract infections in Taiwan. Int J Antimicrob Agents 2004; 23: 438-445.
6. McCormick AW, Whitney CG, Farley MM et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med 2003; 9: 424-430.
7. Nuermberger EL, Bishai WR. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold? Clin Infect Dis 2004; 38(suppl 4): S363-S371.
8. Hsueh PR, Shyr JM, Wu JJ. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan. Clin Infect Dis 2005; 40: 903-905.